Soluclear - Acne Treatment Serum

Description

SoluClear is an acne treatment serum formulated for all skin types. This product is made in the USA and features a water-soluble hemp extract at a concentration of 2.0% and salicylic acid at 0.5%. The serum is presented in a 1 oz (30 ml) dosage form. It is non-GMO, lab tested, paraben-free, cruelty-free, and vegan, ensuring a commitment to quality and ethical standards. The formulation is powered by Thermal Fusion technology, enhancing its efficacy in treating acne.

Uses and Indications

This drug is indicated for the treatment of acne, including acne pimples, as well as for the management of blackheads and whiteheads.

There are no teratogenic effects associated with this drug. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

Healthcare professionals are advised to ensure that the skin is thoroughly cleaned prior to the application of the medication. The affected area should be covered with a thin layer of the product, applied 1 to 3 times daily.

To minimize the risk of excessive drying of the skin, it is recommended to initiate treatment with one application per day. Depending on the patient's response and as directed by a physician, the frequency may be increased to 1 to 3 times daily if necessary.

In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day to alleviate these symptoms.

Contraindications

There are no specific contraindications listed for this product. However, it is imperative to seek medical assistance or contact a Poison Control Center immediately if the product is swallowed.

Warnings and Precautions

The product is intended for external use only. It is imperative that healthcare professionals advise patients to avoid ingestion. In the event of accidental swallowing, immediate medical assistance should be sought, or the individual should contact a Poison Control Center without delay.

Healthcare providers should ensure that patients are aware of these critical safety measures to prevent potential adverse effects associated with improper use.

Side Effects

For external use only. No specific adverse reactions have been reported in clinical trials or postmarketing experiences. Patients should be advised to adhere strictly to the recommended usage guidelines to minimize the risk of adverse effects.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to allow the skin to recover. Monitoring for signs of irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Soluclear - Acne Treatment Serum (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients have not been specifically addressed in the prescribing information. There are no recommended age ranges, dosing differences, safety concerns, or special precautions for children provided in the insert. Therefore, healthcare professionals should exercise caution when considering the use of this medication in pediatric populations, as the efficacy and safety profile in these patients remains undefined.

Geriatric Use

There is no specific information regarding the use of SoluClear Acne Treatment Serum in geriatric patients. The prescribing information does not provide details on dosage adjustments, safety concerns, or special precautions that may be necessary for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this treatment to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

Safety during pregnancy has not been established for this product. The use of this product is contraindicated in pregnancy due to potential risks to the fetus. Salicylic acid, particularly in high doses, may pose a risk to the developing fetus. Therefore, pregnant women should consult a healthcare provider before using this product. It is advised to avoid the use of this product during pregnancy unless directed by a healthcare professional.

Lactation

There are no specific warnings or recommendations regarding the use of this product in nursing mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no specific information regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs.

If available, specific antidotes or treatments should be administered as per established protocols. Additionally, healthcare professionals should consider contacting a poison control center for guidance on the management of overdose cases.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the understanding of potential risks associated with the compound in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed. It is crucial for patients to understand the potential risks associated with accidental ingestion.

Additionally, healthcare providers should inform patients about the likelihood of skin irritation and dryness when using this medication in conjunction with other topical acne treatments. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation. If patients experience any signs of irritation, they should be instructed to discontinue use and consult their healthcare provider for further guidance.

Storage and Handling

The product is supplied in a container that must be kept tightly closed to maintain its integrity. It should be stored at room temperature, ensuring that it is protected from light exposure. Once opened, the product should be discarded to ensure safety and efficacy.

Additional Clinical Information

The route of administration for the medication is topical, with a recommendation to cover the entire affected area with a thin layer 1-3 times daily. To minimize the risk of excessive skin drying, it is advised to start with one application daily, increasing to 1-3 times daily as needed or directed by a clinician. Should bothersome dryness or peeling occur, patients should reduce the application frequency to once a day or every other day.

Clinicians should counsel patients on the potential for skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is important to advise patients to use only one topical acne medication at a time to mitigate irritation. Additionally, patients should be instructed to clean the skin thoroughly before application and to seek medical assistance or contact a Poison Control Center immediately if the medication is swallowed.

Drug Information (PDF)

This file contains official product information for Soluclear - Acne Treatment Serum, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)